Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100841
Status:
COMPLETED
Last Update Posted:
2015-07-27
First Post:
2005-01-06
Brief Title:
Phase II Trial of FOLFOX6 Bevacizumab and Cetuximab in Patients With Colorectal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Rectal Cancer |
| Adenocarcinoma of the Rectum |
| Mucinous Adenocarcinoma of the Colon |
| Recurrent Colon Cancer |
| Recurrent Rectal Cancer |
| Signet Ring Adenocarcinoma of the Colon |
| Stage IV Colon Cancer |
Keywords: